Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-28 to 2025-02-04
Current total value of award: $5285021.76
Description: 8511147946!ADENOVIRUS TYPE 4 A